Testicular cancer in Australia statistics
The following material has been sourced from the Australian Institute of Health and Welfare
Testicular cancer incorporates ICD-10 cancer code C62 (Malignant neoplasm of testis).
Estimated number of new cases of testicular cancer diagnosed in 2020
928 males
Estimated % of all new male cases of cancer diagnosed in 2020
1.2%
Estimated number of deaths from testicular cancer in 2020
30 males
Estimated % of male deaths from cancer in 2020
0.1%
Chance of surviving at least 5 years (2012–2016)
97%
People living with testicular cancer at the end of 2015 (diagnosed in the 5 year period 2011 to 2015)
3,874
New cases
In 2016, there were 850 new cases of testicular cancer diagnosed in Australia. In 2020, it is estimated that 928 new cases of testicular cancer will be diagnosed in Australia.
Figure 1. Estimated most common cancers diagnosed among males, 2020
Notes
- Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
- More information about incidence rates for the most common cancers diagnosed can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence)
In 2016, the age-standardised incidence rate was 7.3 cases per 100,000 males. In 2020, it is estimated that the age-standardised incidence rate will be 7.4 cases per 100,000 males. The incidence rate for testicular cancer is expected to increase with age, peaking at age group 30-34, and then decrease.
Figure 2. Age-standardised incidence rates for testicular cancer, 1982 to 2016
Notes
- Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
The number of new cases of testicular cancer diagnosed increased from 321 in 1982 to 850 in 2016. Over the same period, the age-standardised incidence rate increased from 4.2 cases per 100,000 males in 1982 to 7.3 cases per 100,000 males in 2016.
Deaths
In 2018, there were 34 deaths from testicular cancer in Australia. In 2020, it is estimated that this will decrease to 30 deaths.
Figure 3. Estimated most common causes of cancer death among males, 2020
Notes
- Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
- More information about mortality rates for the most common causes of cancer death can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality)
In 2018, the age-standardised mortality rate was 0.3 deaths per 100,000 males. In 2020, it is estimated that the age-standardised mortality rate will be 0.2 deaths per 100,000 males. The mortality rate for testicular cancer is expected to be similar across age groups.
Figure 4. Age-standardised mortality rates for testicular cancer, 1982 to 2018
Notes
- Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
The number of deaths from testicular cancer was similar in 1982 and 2018 (34 deaths in each year). Over the same period, the age-standardised mortality rate was 0.5 deaths per 100,000 males in 1982 and 0.3 deaths per 100,000 in 2018.
Survival
In 2012–2016, individuals diagnosed with testicular cancer had a 97% chance of surviving for five years compared to their counterparts in the general Australian population. Between 1987–1991 and 2012–2016, five-year relative survival for testicular cancer improved slightly from 95% to 97%.
Figure 5. 5-year relative survival for testicular cancer, 1987–1991 to 2012–2016
Notes
- Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
Prevalence
At the end of 2015, there were 837 males living who had been diagnosed with testicular cancer that year, 3,874 males living who had been diagnosed with testicular cancer in the previous 5 years (from 2011 to 2015) and 17,208 males living who had been diagnosed with testicular cancer in the previous 34 years (from 1982 to 2015).
For more information on cancer data, see the NCCI website
The National Cancer Control Indicators (NCCI) are a set of indicators across the continuum of cancer care, from Prevention and Screening through to Diagnosis, Treatment, Psychosocial care, Research and Outcomes. The NCCI website allows users to see visual representations of data on each indicator through interactive charts.